草稿:3-甲基甲卡西酮

3-甲基甲卡西酮
臨床資料
ATC碼
  • 未分配
法律規範狀態
法律規範
藥物動力學數據
生物利用度口服: 5–9%[2]
血漿蛋白結合率[2]
藥物代謝
生物半衰期50分 (豬)[2]
識別資訊
  • 2-(Methylamino)-1-(3-methylphenyl)propan-1-one
PubChem CID
ChemSpider
UNII
KEGG
化學資訊
化學式C11H15NO
摩爾質量177.25 g·mol−1
3D模型(JSmol英語JSmol
熔點± 0.2°C
  • CC1=CC=CC(C(C(C)NC)=O)=C1
  • InChI=1S/C11H15NO/c1-8-5-4-6-10(7-8)11(13)9(2)12-3/h4-7,9,12H,1-3H3
  • Key:QDNXSIYWHYGMCD-UHFFFAOYSA-N

3-甲基甲卡西酮(亦稱 3-MMC 或 3-Methylmethcathinone),是一種卡西酮衍生物家族的設計毒品。3-MMC 是一種單胺轉運體底物(一種受單胺轉運體作用的物質),能有效釋放和抑制多巴胺去甲腎上腺素的再攝取,並顯示出適度的5-羥色胺釋放活性。[3] [4] [2] [1] [5]

  1. ^ 1.0 1.1 News: March 2023 – UNODC: Seven NPS "scheduled" at the 66th Session of the Commission on Narcotic Drugs. United Nations Office on Drugs and Crime (UNODC). United Nations Office on Drugs and Crime. [29 May 2024]. 
  2. ^ 2.0 2.1 2.2 2.3 Shimshoni JA, Britzi M, Sobol E, Willenz U, Nutt D, Edery N. 3-Methyl-methcathinone: Pharmacokinetic profile evaluation in pigs in relation to pharmacodynamics. Journal of Psychopharmacology. June 2015, 29 (6): 734–43. PMID 25804420. S2CID 26012927. doi:10.1177/0269881115576687. 
  3. ^ Preedy V. Neuropathology of Drug Addictions and Substance Misuse Volume 2: Stimulants, Club and Dissociative Drugs, Hallucinogens, Steroids, Inhalants and International Aspects 2. London: King's College. 2016年4月26日. ISBN 978-0-12-800212-4. 
  4. ^ {{cite journal |vauthors=Luethi D, Kolaczynska KE, Docci L, Krähenbühl S, Hoener MC, Liechti ME |date=May 2018 |title=Pharmacological profile of mephedrone analogs and related new psychoactive substances |url=https://edoc. unibas.ch/57357/1/20170920120908_59c23e44b5f0e.pdf |journal=Neuropharmacology |volume=134 |issue=Pt A |pages=4-12 |doi=10.1016/j.neuropharm.2017
  5. ^ 3-Methylmethcathinone (3-MMC) Critical Review Report (PDF). World Health Organization. (原始內容 (PDF)存檔於2021-11-11).